查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1439500

腸道管理系統 - 全球市場考量、競爭格局、市場預測 (2030)

Bowel Management Systems - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按訂單生產 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

全球腸道管理系統市場規模將於2023年達到14.8億美元，到2030年將達到18.7億美元，預計2024-2030年期間複合年增長率為3.98%。 腸道管理產品的需求不斷增加，主要是由於世界各地老年人口數量不斷增加，他們更容易患腸道相關疾病。 此外，帕金森氏症和中風等神經系統疾病的增加，以及脊髓損傷和創傷引起的神經損傷，也將增加對腸道管理系統的需求。 此外，政府越來越採取舉措，提高人們對腸道疾病預防和管理的認識，批准和推出各種腸道管理產品等，預計也將在預測期內加強腸道管理系統市場。

腸道管理系統的市場動態

目前，由於老年人口負擔日益加重，老年人更容易患腸道疾病，腸道管理系統市場正在快速成長。 這是因為有些人隨著年齡的增長逐漸失去□□肌肉力量。 此外，老年女性比男性更容易發生意外腸漏。 根據《2020年世界老化人口要點》，2020年全球65歲以上人口約7.27億。 報告也預測，到2050年，全球老年人口數量將翻倍，達到15億以上。 報告也指出，同年65歲以上老年人口中，女性約佔55%。

此外，晚期癡呆、多發性硬化症、帕金森氏症（PD）以及脊髓損傷引起的神經損傷等神經系統疾病的增加也是神經源性腸道功能障礙的重要危險因子；這可能是增加神經源性腸道功能障礙的潛在因素。對管理系統的需求。 例如，根據多發性硬化症國際聯合會（2020）的數據，同年全球約有 280 萬人患有多發性硬化症。

此外，交通事故、工傷事故和跌倒造成的創傷增加，可能導致周邊神經損傷，也推動了對腸道管理系統產品的需求。 例如，根據國際勞工組織（ILO）（2022）的數據，全球每年發生約 3.4 億起職業事故。

因此，預計所有上述因素都將增強全球腸道管理系統產品市場。

此外，腸道管理產品的核准預計也將在未來幾年擴大腸道管理系統市場。 例如，2019 年 11 月 22 日，登士柏西諾德的 Navina 智慧型系統和 Navina 經典系統獲得 FDA 批准，旨在用於神經源性腸功能障礙、大便失禁和慢性便秘的患者。

因此，所有上述因素預計將推動腸道管理系統市場的發展。

然而，與使用腸道管理系統相關的不適可能會限制腸道管理系統市場。

由於前所未有的COVID-19大流行，市場對腸道管理系統產品的需求減少。 這是因為，由於世界各地衛生系統的指導方針在封鎖初期暫時側重於管理 COVID-19 患者的數量，因此許多選擇性手術和門診就診暫時停止。 此外，2020年下半年，多種COVID-19疫苗在全球範圍內獲得批准和使用，顯著改善了包括醫療服務在內的各個領域的活動恢復情況，從而有助於腸道管理系統市場的健康復甦。

腸道管理系統市場區隔分析

在腸道管理系統產品領域，神經調節設備預計將在預測期內佔據重要的市場份額。 這是由於大腦、脊髓和周邊神經創傷病例的增加導致神經性腸道疾病的增加。 例如，根據澳洲脊髓損傷報告（2022 年），同年有超過 15,000 名澳洲人患有脊髓損傷，其中 46% 的人受到汽車乘客、摩托車手、行人、踏板自行車和四輪摩托車的影響。36 % 的脊髓損傷由交通事故造成，而涉及未受保護的陸地交通使用者的陸上交通事故，例如

本報告研究和分析了全球腸道管理系統市場，提供市場規模和預測、驅動因素和挑戰、公司和產品概況等。

目錄

第1章腸道管理系統市場報告簡介

第 2 章腸道管理系統市場執行摘要

  • 調查範圍
  • 市場概覽
  • 競爭評估
  • 財務基準

第3章監理與專利分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第4章腸道管理系統市場主要因素分析

  • 腸道管理系統市場驅動因素
    • 老年人口數量增加，更容易罹患腸道疾病
    • 神經系統疾病的擴展，這是發生腸失禁的危險因子之一
    • 政府加強提高人們對腸道疾病管理的認識
    • 神經損傷加劇
  • 腸道管理系統市場的限制與挑戰
    • 某些腸道管理系統有嚴格的監管審批流程
    • 患者對腸失禁非侵入性臨床治療的偏好
  • 腸道管理系統市場機遇
    • 低收入和中等收入國家的機遇
    • 非侵入性腸道管理設備的機遇

第5章波特腸道管理系統五力分析

第6章COVID-19對腸道管理系統市場的影響分析

第7章腸道管理系統市場佈局

  • 依產品類型
    • 設備
    • 配件
  • 依患者類型
    • 成人
    • 兒童
  • 最終用戶
    • 醫院
    • 門診手術中心
    • 居家護理
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他領域

第 8 章腸道管理系統：全球公司份額分析 - 3 至 5 家主要公司

第9章腸道管理系統公司及產品簡介

  • Medtronic
  • Coloplast Corp
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • ConvaTec Inc.
  • Laborie
  • Consure Medical
  • Axonics, Inc
  • Renew Medical Inc
  • Hollister Incorporated
  • Welland Medical Limited.
  • Wellspect HealthCare (Dentsply Sirona Company)
  • Restech.
  • Bioness, Inc.
  • A.M.I. GmbH
  • ProSys International Ltd
  • Angiplast Pvt Ltd.
  • Marlen Manufacturing & Development Company

第10章KOL觀看次數

第 11 章專案方法

第 12 章關於 DelveInsight

第 13 章免責聲明與聯絡我們

Product Code: DIMDCL0318

Bowel Management Systems Market By Product Type ( Devices [Irrigation Systems, Nerve Modulation Devices, Others] Accessories), By Patient Type (Adult And Pediatrics), By End-User (Hospitals, Ambulatory Surgical Centres, And Home Care), and by geography is projected to expand at a noteworthy CAGR forecast till 2030 owing to the growing burden of aging population, worldwide and rising neurological disorders

The global bowel management systems market was valued at USD 1.48 billion in 2023, growing at a CAGR of 3.98% during the forecast period from 2024 to 2030, in order to reach USD 1.87 billion by 2030. The increase in demand for bowel management products is primarily attributed to the increasing geriatric population across the globe who are more susceptible to developing bowel-associated disorders. In addition, rising neurological disorders such as Parkinson's disease, stroke, among others, and growing cases of nerve injuries due to spinal cord injuries, trauma injuries, and others would also increase the demand for bowel management systems as these factors most often lead to bowel incontinences. Also, rising government initiatives to raise awareness regarding prevention and management of bowel control issues, approval and launch of various bowel management products, among others are anticipated to bolster the market for bowel management systems during the forecasted period.

Bowel Management Systems Market Dynamics:

The market for bowel management systems is gaining pace at present due to the rising burden of the geriatric population who are prone to develop bowel disorders. This is because some people gradually lose muscle strength as they age. In addition, older women experience accidental bowel leakage more often as compared to men. According to the World Ageing Population 2020 Highlights, there were about 727 million people aged 65 years or over in the world in 2020. The report also projected the global number of older persons to double reaching over 1.5 billion in 2050. In addition, the report also mentioned that women accounted for about 55% of the older population aged 65 years or over in the same year.

Moreover, an increase in neurological disorders such as advanced dementia, multiple sclerosis, Parkinson's disease (PD), or nerve injuries due to spinal cord injuries, and others could also be potential factors that would increase the demand for bowel management systems as these are the significant risk factors for neurogenic bowel dysfunction. For instance, as per the Multiple Sclerosis International Federation 2020 data, approximately 2.8 million people were living with multiple sclerosis around the globe in the same year.

Additionally, rising cases of traumatic injuries due to road accidents, occupational accidents, and falls, among others could lead to peripheral nerve injuries thereby raising the demand for Bowel Management Systems products. For instance, according to the International Labour Organization (ILO) 2022 data, worldwide, there are approximately 340 million occupational accidents annually.

Hence, all the above-mentioned factors are expected to bolster the global market for Bowel Management Systems products.

Furthermore, approval of bowel management products would also augment the market for bowel management systems in the forthcoming years. For instance, on November 22, 2019, Dentsply Sirona received FDA approval for Navina Smart System and Navina Classic System intended for use in patients with neurogenic bowel dysfunction, fecal incontinence, and chronic constipation.

Thus, all the aforementioned factors are expected to propel the bowel management systems market.

However, the discomfort associated with the use of bowel management systems is likely to impede the market for bowel management systems.

With the unprecedented COVID-19 pandemic the demand for Bowel Management Systems products in the market decreased. This was due to the temporary suspension of numerous elective procedures and outpatient visits as the healthcare system guidelines worldwide temporarily focused all their efforts on the management of COVID-19 patient load during the initial lockdown period. Moreover, owing to the approval and administration of numerous COVID-19 vaccines across the globe in the second half of 2020, there was a significant improvement in the resumption of activities across various domains, including healthcare services, thereby paving the way for a sound period of recovery for the Bowel Management Systems market.

Bowel Management Systems Market Segment Analysis:

Bowel Management Systems Market By Product Type (Devices [Irrigation Systems, Nerve Modulation Devices, Others] Accessories), By Patient Type (Adult and Pediatrics), By End-User (Hospitals, Ambulatory Surgical Centres, and Homecare), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the Bowel Management Systems product segment, the nerve modulation devices are anticipated to hold a significant market share during the forecasted period. This is owing to the increase in neurogenic bowel disorders due to an increase in cases of trauma to the brain, spinal cord, or peripheral nerves. For instance, according to the Spinal Cord Injuries Australia 2022, more than 15,000 Australians were living with a spinal cord injury in the same year out of which 46% are due to land transport crashes involving motor vehicle occupants and unprotected land transport users such as motorcyclists, pedestrians, pedal cyclists and quad bikes whereas falls contribute to 36% of spinal cord injuries.

Furthermore, the rising focus towards R&D activities by the government organization and manufacturing companies for the development of nerve modulation devices for the management of bowel disorders such as irritable bowel syndrome, accidental bowel leakage, and others are projected to contribute to the market growth.

For instance, NICHD (National Institute of Child Health and Human Development) Pelvic Floor Disorders Network has completed a clinical trial in the year 2020 for device ES-130, a neuromodulation device for accidental bowel leakage.

Moreover, an increase in product approval for nerve modulation bowel management devices will contribute to the market growth. For instance, in January 2020, Bioness, Inc., the leading provider of advanced, clinically supported medical devices for the treatment of chronic pain of peripheral nerve origin, received CE mark approval for its StimRouter® Neuromodulation System indicated for the treatment of faecal incontinence (FI) across Europe.

Hence, all the interplay of all the above-mentioned factors will contribute to the segmental growth of the bowel management systems market in the upcoming years.

North America is expected to dominate the overall Bowel Management Systems Market:

Among all the regions, North America is expected to occupy a major share in the overall Bowel Management Systems market in the year 2020 and is expected to hold its position during the forecasted period. This domination is due to the rise in the target population in the region. In addition, an increase in neurological conditions, the presence of leading bowel management systems companies, and favourable reimbursement policies, among others are expected to surge the demand for the bowel management systems market.

The rising prevalence of Parkinson's disease in the region would contribute to the bowel management systems market. This is because faecal incontinence is a very debilitating symptom that can occur in advanced PD thereby leading to an increase in the demand for bowel management products. For instance, as per the Parkinson's Foundation 2022, approximately 1.2 million people in the US are estimated to suffer from Parkinson's disease by the year 2030.

In addition, as per the 2022 data published by Crohn's and Colitis Canada, Persons with Crohn's disease or ulcerative colitis (together, inflammatory bowel disease [IBD]) make up more than 0.75% of the Canadian population in 2022. The disease affects over 300,000 Canadians which is expected to rise to 400,000 (1% of the population) by 2030. Thus, the rising population with bowel dysfunction and neurological disorders who are susceptible to developing bowel disorders would contribute to the growth of the regional bowel management systems market.

Moreover, product approvals in the region for the treatment of bowel discomfort are also expected to bolster the demand for bowel management systems in the country. For instance, on September 06, 2019, Axonics Modulation Technologies, Inc. received FDA clearance for its Axonics Sacral Neuromodulation System indicated for the treatment of chronic faecal incontinence in patients who have failed or are not candidates for other treatments, such as medications or physical therapy.

Further, the Asia Pacific region has future potential for the bowel management systems market. This is predominantly owing to the rising geriatric population, growing patient pool, increase in government initiatives to raise awareness regarding the proper management of bowel-associated disorders, and others. For instance, as per the Continence Foundation of Australia 2022 data, by 2030 over 6.2 million Australians will be affected by bowel or bladder incontinence. Furthermore, the Australian Government supports prevention and management of incontinence through three initiatives: National Continence Program (NCP), Continence Aids Payment Scheme (CAPS), and Stoma Appliance Scheme. In addition, improving healthcare infrastructure, rising disposable income, among others also some of the factors responsible for bowel management systems market growth in the region during the forthcoming years.

Bowel Management Systems Market Key Players:

Some of the key market players operating in the Bowel Management Systems market include Coloplast Corp, Medtronic, B. Braun Melsungen AG, Becton, Dickinson and Company, ConvaTec Inc., Laborie., Consure Medical, Axonics, Inc., Renew Medical Inc, Hollister Incorporated, Welland Medical Limited., Wellspect HealthCare (Dentsply Sirona Company) Restech., Bioness, Inc., A.M.I. GmbH, ProSys International Ltd, Angiplast Pvt Ltd., Marlen Manufacturing & Development Company., among others.

Recent Developmental Activities in the Bowel Management Systems Market:

In October 2022, Laborie Medical Technologies Corp. (Laborie) a specialist medical technology company, acquired Pelvalon, Inc., a privately-held medical device company located in Redwood City, CA which has developed an innovative product called the Eclipse(TM) System, a non-surgical, patient-controlled device for women suffering from faecal incontinence (FI).

In May 2022, Axonics, Inc., a global medical technology company focused on developing and commercializing novel products for the treatment of bladder and bowel dysfunction, received European CE Mark approval for its second-generation Axonics r-SNM® implantable neurostimulator (INS) and wireless patient remote control with SmartMRI(TM) technology.

In August 2020, Medtronic plc received approval from the US FDA for its InterStim(TM) Micro neurostimulator and InterStim(TM) SureScan(TM) MRI leads used for treating overactive bladder (OAB), faecal incontinence (FI), and non-obstructive urinary retention.

Key Takeaways from the Bowel Management Systems Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Bowel Management Systems market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the Global Bowel Management Systems Market.

Various opportunities available for the other competitor in the Bowel Management Systems Market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Bowel Management Systems market growth in the coming future?

Target Audience who can be benefited from the Bowel Management Systems Market Report Study

Bowel Management Systems providers

Research organizations and consulting companies

Bowel Management Systems-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in Bowel Management Systems

Various End-users want to know more about the Bowel Management Systems Market and the latest technological developments in the Bowel Management Systems market.

Frequently Asked Questions for the Bowel Management Systems Market:

1. What is Bowel Management Systems?

Bowel incontinence, also known as faecal incontinence is generally the situation when the patient is not able to control bowel movements which results in involuntary loss of solid or liquid stool. The clinical devices used to manage bowel activity are called bowel management systems.

2. What is the market for Global Bowel Management Systems?

The global bowel management systems market was valued at USD 1.48 billion in 2023, growing at a CAGR of 3.98% during the forecast period from 2024 to 2030, in order to reach USD 1.87 billion by 2030.

3. What are the drivers for the Global Bowel Management Systems?

The major factors driving the demand for Bowel Management Systems are the rising cases of nerve injuries, increase in the geriatric population, growing neurological disorders. In addition, rising government initiatives to raise awareness regarding bowel incontinence management and approval and launch of advanced products, among others are expected to drive the market.

4. What are the key players operating in Global Bowel Management Systems?

Some of the key market players operating in the Bowel Management Systems market include Coloplast Corp, Medtronic, B. Braun Melsungen AG, Becton, Dickinson and Company, ConvaTec Inc., Laborie., Consure Medical, Axonics, Inc., Renew Medical Inc, Hollister Incorporated, Welland Medical Limited., Wellspect HealthCare (Dentsply Sirona Company) Restech., Bioness, Inc., A.M.I. GmbH, ProSys International Ltd, Angiplast Pvt Ltd., Marlen Manufacturing & Development Company., among others.

5. Which region has the highest share in the Bowel Management Systems market?

Among all the regions, North America is expected to occupy a major share in the overall Bowel Management Systems market in the year 2023 and is expected to hold its position during the forecasted period. This domination is due to the rise in the target population in the region. In addition, an increase in neurological conditions, the presence of leading bowel management systems companies, and favourable reimbursement policies, among others are expected to surge the demand for the bowel management systems market.

Table of Contents

1.Bowel Management Systems Market Report Introduction

2.Bowel Management Systems Market Executive summary

  • 2.1 Scope of the Study
  • 2.2 Market at Glance
  • 2.3 Competitive Assessment
  • 2.4 Financial Benchmarking

3. Regulatory and Patent Analysis

  • 3.1 The United States
  • 3.2 Europe
  • 3.3 Japan
  • 3.4 China

4. Bowel Management Systems Market Key factors analysis

  • 4.1 Bowel Management Systems Market Drivers
    • 4.1.1 The rising geriatric population who are prone to develop bowel disorders
    • 4.1.2 Growing neurological disorders which is one of the risk factors for developing bowel incontinence
    • 4.1.3 Rising government initiatives to raise awareness regarding bowel disorder management
    • 4.1.4 Rising nerve injuries
  • 4.2 Bowel Management Systems Market Restraints and Challenges
    • 4.2.1 The stringent regulatory approval process of some bowel management systems
    • 4.2.2 Patient preference for non-invasive clinical management of bowel incontinence
  • 4.3 Bowel Management Systems Market Opportunities
    • 4.3.1 Opportunities in low- and middle-income nations
    • 4.3.2 Opportunities for non-invasive bowel management devices

5. Bowel Management Systems Porter's Five Forces Analysis

  • 5.1 Bargaining Power of Suppliers
  • 5.2 Bargaining Power of Consumers
  • 5.3 Threat of New Entrants
  • 5.4 Threat of Substitutes
  • 5.5 Competitive Rivalry

6. COVID-19 Impact Analysis on Bowel Management Systems Market

7. Bowel Management Systems Market layout

  • 7.1 By Product Type
    • 7.1.1 Devices
      • 7.1.1.1 Irrigation Systems
      • 7.1.1.2 Nerve Modulation Devices
      • 7.1.1.3 Others
    • 7.1.2 Accessories
  • 7.2 By Patient Type
    • 7.2.1 Adult
    • 7.2.2 Pediatrics
  • 7.3 End-User
    • 7.3.1 Hospitals
    • 7.3.2 Ambulatory Surgical Centres
    • 7.3.3 Home Care
  • 7.4 By Geography
    • 7.4.1 North America
      • 7.4.1.1 North America Bowel Management Systems Market, by Product Type
      • 7.4.1.2 North America Bowel Management Systems Market, by Patient Type
      • 7.4.1.3 North America Bowel Management Systems Market, by End User
      • 7.4.1.4 North America Bowel Management Systems Market, by Country
      • 7.4.1.4.1 United States
      • 7.4.1.4.2 Canada
      • 7.4.1.4.3 Mexico
    • 7.4.2 Europe
      • 7.4.2.1 Europe Bowel Management Systems Market, by Product Type
      • 7.4.2.2 Europe Bowel Management Systems Market, by Patient Type
      • 7.4.2.3 Europe Bowel Management Systems Market, by End User
      • 7.4.2.4 Europe Bowel Management Systems Market, by Country
      • 7.4.2.4.1 France
      • 7.4.2.4.2 Germany
      • 7.4.2.4.3 United Kingdom
      • 7.4.2.4.4 Italy
      • 7.4.2.4.5 Spain
      • 7.4.2.4.6 Russia
      • 7.4.2.4.7 Rest of Europe
    • 7.4.3 Asia-Pacific
      • 7.4.3.1 Asia-Pacific Bowel Management Systems Market, by Product Type
      • 7.4.3.2 Asia-Pacific Bowel Management Systems Market, by Patient Type
      • 7.4.3.3 Asia-Pacific Bowel Management Systems Market, by End User
      • 7.4.3.4 Asia-Pacific Bowel Management Systems Market, by Country
      • 7.4.3.4.1 China
      • 7.4.3.4.2 Japan
      • 7.4.3.4.3 India
      • 7.4.3.4.4 Australia
      • 7.4.3.4.5 South Korea
      • 7.4.3.4.6 Rest of Asia Pacific
    • 7.4.4 Rest of the World (RoW)
      • 7.4.4.1 RoW Bowel Management Systems Market, by Product Type
      • 7.4.4.2 RoW Bowel Management Systems Market, by Patient Type
      • 7.4.4.3 RoW Bowel Management Systems Market, by End User
      • 7.4.4.4 RoW Bowel Management Systems Market, by Region
      • 7.4.4.4.1 Middle East
      • 7.4.4.4.2 Africa
      • 7.4.4.4.3 South America

8. Bowel Management Systems Global Company Share Analysis - Key 3-5 Companies

9. Bowel Management Systems Company and Product Profiles

  • 9.1 Medtronic
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4 Product Listing
    • 9.1.5. Entropy
  • 9.2 Coloplast Corp
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4 Product Listing
    • 9.2.5. Entropy
  • 9.3 B. Braun Melsungen AG
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4 Product Listing
    • 9.3.5. Entropy
  • 9.4 Becton, Dickinson and Company
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4 Product Listing
    • 9.4.5. Entropy
  • 9.5 ConvaTec Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4 Product Listing
    • 9.5.5. Entropy
  • 9.6 Laborie
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4 Product Listing
    • 9.6.5. Entropy
  • 9.7 Consure Medical
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4 Product Listing
    • 9.7.5. Entropy
  • 9.8 Axonics, Inc
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4 Product Listing
    • 9.8.5. Entropy
  • 9.9 Renew Medical Inc
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4 Product Listing
    • 9.9.5. Entropy
  • 9.10 Hollister Incorporated
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4 Product Listing
    • 9.10.5. Entropy
  • 9.11 Welland Medical Limited.
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4 Product Listing
    • 9.11.5. Entropy
  • 9.12 Wellspect HealthCare (Dentsply Sirona Company)
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4 Product Listing
    • 9.12.5. Entropy
  • 9.13 Restech.
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4 Product Listing
    • 9.13.5. Entropy
  • 9.14 Bioness, Inc.
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4 Product Listing
    • 9.14.5. Entropy
  • 9.15 A.M.I. GmbH
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4 Product Listing
    • 9.15.5. Entropy
  • 9.16 ProSys International Ltd
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4 Product Listing
    • 9.16.5. Entropy
  • 9.17 Angiplast Pvt Ltd.
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4 Product Listing
    • 9.17.5. Entropy
  • 9.18 Marlen Manufacturing & Development Company
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4 Product Listing
    • 9.18.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us

List of Tables

  • Table 1 Competitive Analysis
  • Table 2 COVID-19 Impact Analysis on Bowel Management Systems Market
  • Table 3 Bowel Management Systems Market Analysis in Global (2021-2030)
  • Table 4 Bowel Management Systems Market Analysis in Global by Product Type (2021-2030)
  • Table 5 Bowel Management Systems Market Analysis in Global by Patient Type (2021-2030)
  • Table 6 Bowel Management Systems Market Analysis in Global by End User (2021-2030)
  • Table 7 Bowel Management Systems Market Analysis in Global by Geography (2021-2030)
  • Table 8 Bowel Management Systems Market Analysis in North America (2021-2030)
  • Table 9 Bowel Management Systems Market Analysis in North America by Product Type (2021-2030)
  • Table 10 Bowel Management Systems Market Analysis in North America by Patient Type (2021-2030)
  • Table 11 Bowel Management Systems Market Analysis in North America by End User (2021-2030)
  • Table 12 Bowel Management Systems Market Analysis in North America by Country (2021-2030)
  • Table 13 Bowel Management Systems Market Analysis in the US (2021-2030)
  • Table 14 Bowel Management Systems Market Analysis in Canada (2021-2030)
  • Table 15 Bowel Management Systems Market Analysis in Mexico (2021-2030)
  • Table 16 Bowel Management Systems Market Analysis in Europe (2021-2030)
  • Table 17 Bowel Management Systems Market Analysis in Europe by Product Type (2021-2030)
  • Table 18 Bowel Management Systems Market Analysis in Europe by Patient Type (2021-2030)
  • Table 19 Bowel Management Systems Market Analysis in Europe by End User (2021-2030)
  • Table 20 Bowel Management Systems Market Analysis in Europe by Country (2021-2030)
  • Table 21 Bowel Management Systems Market Analysis in France (2021-2030)
  • Table 22 Bowel Management Systems Market Analysis in Germany (2021-2030)
  • Table 23 Bowel Management Systems Market Analysis in the UK (2021-2030)
  • Table 24 Bowel Management Systems Market Analysis in Italy (2021-2030)
  • Table 25 Bowel Management Systems Market Analysis in Spain (2021-2030)
  • Table 26 Bowel Management Systems Market Analysis in Russia (2021-2030)
  • Table 27 Bowel Management Systems Market Analysis in Rest of Europe (2021-2030)
  • Table 28 Bowel Management Systems Market Analysis in Asia-Pacific (2021-2030)
  • Table 29 Bowel Management Systems Market Analysis in Asia-Pacific by Product Type (2021-2030)
  • Table 30 Bowel Management Systems Market Analysis in Asia-Pacific by Patient Type (2021-2030)
  • Table 31 Bowel Management Systems Market Analysis in Asia-Pacific by End User (2021-2030)
  • Table 32 Bowel Management Systems Market Analysis in Asia-Pacific by Country (2021-2030)
  • Table 33 Bowel Management Systems Market Analysis in China (2021-2030)
  • Table 34 Bowel Management Systems Market Analysis in Japan (2021-2030)
  • Table 35 Bowel Management Systems Market Analysis in India (2021-2030)
  • Table 36 Bowel Management Systems Market Analysis in Australia (2021-2030)
  • Table 37 Bowel Management Systems Market Analysis in South Korea (2021-2030)
  • Table 38 Bowel Management Systems Market Analysis in Rest of Asia-Pacific (2021-2030)
  • Table 39 Bowel Management Systems Market Analysis in Rest of World (2021-2030)
  • Table 40 Bowel Management Systems Market Analysis in Rest of World by Product Type (2021-2030)
  • Table 41 Bowel Management Systems Market Analysis in Rest of World by Patient Type (2021-2030)
  • Table 42 Bowel Management Systems Market Analysis in Rest of World by End User (2021-2030)
  • Table 43 Bowel Management Systems Market Analysis in Rest of World by Country (2021-2030)
  • Table 44 Bowel Management Systems Market Analysis in the Middle East (2021-2030)
  • Table 45 Bowel Management Systems Market Analysis in Africa (2021-2030)
  • Table 46 Bowel Management Systems Market Analysis in South America (2021-2030)

List of Figures

  • Figure 1 Competitive Analysis
  • Figure 2 COVID-19 Impact Analysis on Bowel Management Systems Market
  • Figure 3 Bowel Management Systems Market Analysis in Global (2021-2030)
  • Figure 4 Bowel Management Systems Market Analysis in Global by Product Type (2021-2030)
  • Figure 5 Bowel Management Systems Market Analysis in Global by Patient Type (2021-2030)
  • Figure 6 Bowel Management Systems Market Analysis in Global by End User (2021-2030)
  • Figure 7 Bowel Management Systems Market Analysis in Global by Geography (2021-2030)
  • Figure 8 Bowel Management Systems Market Analysis in North America (2021-2030)
  • Figure 9 Bowel Management Systems Market Analysis in North America by Product Type (2021-2030)
  • Figure 10 Bowel Management Systems Market Analysis in North America by Patient Type (2021-2030)
  • Figure 11 Bowel Management Systems Market Analysis in North America by End User (2021-2030)
  • Figure 12 Bowel Management Systems Market Analysis in North America by Country (2021-2030)
  • Figure 13 Bowel Management Systems Market Analysis in the US (2021-2030)
  • Figure 14 Bowel Management Systems Market Analysis in Canada (2021-2030)
  • Figure 15 Bowel Management Systems Market Analysis in Mexico (2021-2030)
  • Figure 16 Bowel Management Systems Market Analysis in Europe (2021-2030)
  • Figure 17 Bowel Management Systems Market Analysis in Europe by Product Type (2021-2030)
  • Figure 18 Bowel Management Systems Market Analysis in Europe by Patient Type (2021-2030)
  • Figure 19 Bowel Management Systems Market Analysis in Europe by End User (2021-2030)
  • Figure 20 Bowel Management Systems Market Analysis in Europe by Country (2021-2030)
  • Figure 21 Bowel Management Systems Market Analysis in France (2021-2030)
  • Figure 22 Bowel Management Systems Market Analysis in Germany (2021-2030)
  • Figure 23 Bowel Management Systems Market Analysis in the UK (2021-2030)
  • Figure 24 Bowel Management Systems Market Analysis in Italy (2021-2030)
  • Figure 25 Bowel Management Systems Market Analysis in Spain (2021-2030)
  • Figure 26 Bowel Management Systems Market Analysis in Russia (2021-2030)
  • Figure 27 Bowel Management Systems Market Analysis in Rest of Europe (2021-2030)
  • Figure 28 Bowel Management Systems Market Analysis in Asia-Pacific (2021-2030)
  • Figure 29 Bowel Management Systems Market Analysis in Asia-Pacific by Product Type (2021-2030)
  • Figure 30 Bowel Management Systems Market Analysis in Asia-Pacific by Patient Type (2021-2030)
  • Figure 31 Bowel Management Systems Market Analysis in Asia-Pacific by End User (2021-2030)
  • Figure 32 Bowel Management Systems Market Analysis in Asia-Pacific by Country (2021-2030)
  • Figure 33 Bowel Management Systems Market Analysis in China (2021-2030)
  • Figure 34 Bowel Management Systems Market Analysis in Japan (2021-2030)
  • Figure 35 Bowel Management Systems Market Analysis in India (2021-2030)
  • Figure 36 Bowel Management Systems Market Analysis in Australia (2021-2030)
  • Figure 37 Bowel Management Systems Market Analysis in South Korea (2021-2030)
  • Figure 38 Bowel Management Systems Market Analysis in Rest of Asia-Pacific (2021-2030)
  • Figure 39 Bowel Management Systems Market Analysis in Rest of World (2021-2030)
  • Figure 40 Bowel Management Systems Market Analysis in Rest of World by Product Type (2021-2030)
  • Figure 41 Bowel Management Systems Market Analysis in Rest of World by Patient Type (2021-2030)
  • Figure 42 Bowel Management Systems Market Analysis in Rest of World by End User (2021-2030)
  • Figure 43 Bowel Management Systems Market Analysis in Rest of World by Country (2021-2030)
  • Figure 44 Bowel Management Systems Market Analysis in the Middle East (2021-2030)
  • Figure 45 Bowel Management Systems Market Analysis in Africa (2021-2030)
  • Figure 46 Bowel Management Systems Market Analysis in South America (2021-2030)
  • Figure 47 Market Drivers
  • Figure 48 Market Barriers
  • Figure 49 Market Opportunities
  • Figure 50 PORTER's Five Force Analysis